{
  "info": {
    "nct_id": "NCT00061308",
    "official_title": "An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer",
    "criteria": "Inclusion Criteria:\n\n* Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease.\n* At least 4 weeks since last surgery or radiation therapy.\n* Must have had a treatment-free interval of greater than 6 months following response to platinum.\n* ECOG performance status of 0,1, or 2.\n\nExclusion Criteria:\n\n* Women of child-bearing potential that do not practice adequate contraception.\n* Pregnant or lactating.\n* Received more than one primary chemotherapy regimen.\n* Concomitant or previous malignancies with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, incidental carcinoid, or other cancer from which the patient has been disease free for 5 years.\n* Active uncontrolled infection requiring antibiotics.\n* Concurrent severe medical problems unrelated to the malignancy which would limit full compliance with the study.\n* Received radiation to more than 10% of bone.\n* Prior treatment with topotecan or gemcitabine.\n* Hypersensitivity to camptothecin or nucleoside analogues.\n* Use of an investigational agent within 30 days."
  },
  "atomic_criteria": [
    {
      "raw_text": "Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease.",
      "paraphrased_text": "The patient must have previously undergone one platinum-based chemotherapy regimen for their primary disease."
    },
    {
      "raw_text": "Must have had a treatment-free interval of greater than 6 months following response to platinum.",
      "paraphrased_text": "The patient must have had a treatment-free interval of more than 6 months after responding to platinum treatment."
    },
    {
      "raw_text": "Exclusion Criteria:",
      "paraphrased_text": "This section lists conditions or factors that disqualify a participant from the trial."
    },
    {
      "raw_text": "Women of child-bearing potential",
      "paraphrased_text": "The participant must be a woman of child-bearing potential."
    },
    {
      "raw_text": "do not practice adequate contraception",
      "paraphrased_text": "The participant does not practice adequate contraception."
    },
    {
      "raw_text": "Pregnant",
      "paraphrased_text": "The patient is pregnant."
    },
    {
      "raw_text": "lactating",
      "paraphrased_text": "The patient is lactating."
    },
    {
      "raw_text": "Received more than one primary chemotherapy regimen",
      "paraphrased_text": "The patient must have received more than one primary chemotherapy regimen."
    },
    {
      "raw_text": "Concomitant or previous malignancies",
      "paraphrased_text": "The patient must not have concomitant or previous malignancies."
    },
    {
      "raw_text": "adequately treated basal cell or squamous cell skin cancer",
      "paraphrased_text": "The patient may have had adequately treated basal cell or squamous cell skin cancer."
    },
    {
      "raw_text": "in situ cervical cancer",
      "paraphrased_text": "The patient may have had in situ cervical cancer."
    },
    {
      "raw_text": "incidental carcinoid",
      "paraphrased_text": "The patient may have had incidental carcinoid."
    },
    {
      "raw_text": "other cancer from which the patient has been disease free for 5 years",
      "paraphrased_text": "The patient may have had another cancer if they have been disease free for 5 years."
    },
    {
      "raw_text": "Active uncontrolled infection requiring antibiotics.",
      "paraphrased_text": "The patient must have an active uncontrolled infection that requires antibiotics."
    },
    {
      "raw_text": "Concurrent severe medical problems unrelated to the malignancy",
      "paraphrased_text": "The patient has severe medical problems that are not related to the cancer."
    },
    {
      "raw_text": "which would limit full compliance with the study",
      "paraphrased_text": "The patient's condition would prevent them from fully complying with the study requirements."
    },
    {
      "raw_text": "Received radiation to more than 10% of bone.",
      "paraphrased_text": "The patient has received radiation to more than 10% of their bone."
    },
    {
      "raw_text": "Use of an investigational agent within 30 days.",
      "paraphrased_text": "The patient has used an investigational agent in the last 30 days."
    }
  ],
  "leftovers": [
    "Inclusion Criteria:",
    "* ",
    "* ",
    "* ",
    " that ",
    ".",
    "* ",
    " or ",
    ".",
    "* ",
    ".",
    "* ",
    " with the exception of ",
    ", ",
    ", ",
    ", or ",
    ".",
    "* ",
    "* ",
    " ",
    ".",
    "* ",
    "* "
  ]
}